Latest News about SNY
Recent news which mentions SNY
   Amgen's Adcomm Meeting Paves Way To Launch Boost For Mirati Therapeutics' Lung Cancer Drug: Analysts
   
  
  
  October 06, 2023
  From Benzinga
 
   What's Going On With Mirati Therapeutics Stock?
   
  
  
  October 06, 2023
  From Benzinga
 From Benzinga
 
   Teva partnership with Sanofi ‘will pay dividends,’ analyst says
   
  
  
  October 04, 2023
  From MarketWatch
 
   Sanofi, Teva Pledge $1.5B To Target Inflammatory Bowel Disease That Impacts Almost 10M People
   
  
  
  October 04, 2023
  From Benzinga
 From Benzinga
 
   Why Shares of Kymera Therapeutics Jumped on Tuesday
   
  
  
  October 03, 2023
  From Motley Fool
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   Stock Split Watch: Is Regeneron Pharmaceuticals Next?
   
  
  
  September 30, 2023
  From Motley Fool
 
   Dianthus' Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand - Analyst
   
  
  
  September 28, 2023
  From Benzinga
 
   Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
   
  
  
  September 27, 2023
  From Benzinga
 
   Weight Loss Drugs Like Wegovy Could Have Linked Anesthesia Complications, European Medicines Agency To Investigate
   
  
  
  September 27, 2023
  From Benzinga
 
   Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
   
  
  
  September 26, 2023
  From Benzinga
 
   CDC Backs Pfizer's RSV Infection Maternal Vaccine During Pregnancy As Protection For Infants
   
  
  
  September 25, 2023
  From Benzinga
 
   Pfizer maternal RSV vaccine recommended by CDC advisers
   
  
  
  September 22, 2023
  From MarketWatch
 
   Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit
   
  
  
  September 21, 2023
  From Benzinga
 
   Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
   
  
  
  September 21, 2023
  From Benzinga
 
   Gold Down Over 1%; FedEx Shares Rise On Earnings Beat
   
  
  
  September 21, 2023
  From Benzinga
 
   Nasdaq Down Over 1%; US Initial Jobless Claims Fall More Than Expected
   
  
  
  September 21, 2023
  From Benzinga
 From Benzinga
 From Benzinga
 
   FDA Rejects EpiPen Alternative - ARS Pharmaceuticals' Allergic Reaction Nasal Spray
   
  
  
  September 20, 2023
  From Benzinga
 
   3 Stocks to Buy to Ride Europe’s Coming Market Surge
   
  
  
  September 19, 2023
  From InvestorPlace
 
   Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs
   
  
  
  September 14, 2023
  From Benzinga
 
   This Market Could Be Worth $10 Billion by 2030 -- 2 Stocks to Buy Now
   
  
  
  September 14, 2023
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.